---
title: "tax_323"
date: "2024-09-28"
tags:
  - building
---

> [!NOTE]
> ðŸŒ± created from: [[role_of_induction_chemotherapy-of-hnscc]]

# tax_323

TPF

As compared with the standard regimen of cisplatin and fluorouracil, induction chemotherapy with the addition of docetaxel significantly improved progression-free and overall survival in patients with unresectable squamous-cell carcinoma of the head and neck. (ClinicalTrials.gov number, NCT00003888.)

> 1.Vermorken JB. Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck Cancer. The New England Journal of Medicine. Published October 25, 2007. Accessed September 28, 2024. <https://www-nejm-org.erm.kfsyscc.org:8443/doi/full/10.1056/NEJMoa071028>
